Tessellon's forecasting and epidemiology tools and services are vital to developing the certainty required in today's pharmaceutical market. Our pharmaceutical clients from the U.S., Europe and Japan appreciate our dedication to achieving success

Achieved a high level of proficiency in many therapeutic areas of the pharmaceutical industry, including cardiovascular, metabolic conditions, oncology, CNS, urology, women’s health, gastroenterology, hematology, infectious disease, immunology, and others. Experience includes the diagnostic and procedure aspects of the healthcare industry. Specific capabilities include product forecasting, epidemiology and patient segmentation, market analysis, primary and secondary market research, new product positioning, unmet need analysis (commercial/scientific/clinical), in-license/out-license opportunity analysis, business development, and strategic portfolio analysis. Responsible for inventing, designing and bringing to market several key syndicated information services and products and driving significant company revenue with such services and products.

Responsible for initiating, organizing and directing a research and development program in magnetic resonance, ultrasound and fluorine imaging. As Director of Imaging, coordinated and supervised synthetic and analytical chemistry efforts, pharmacological/toxicological support of projects, and performed animal imaging studies. Within one year this program lead to the discovery of two new targeted imaging agents for MRI and one new agent for ultrasound imaging that entered formal pre-clinical development. Responsible for pursuing licensing arrangements for new products worldwide (US, Europe and Japan). Organized external collaborative research programs, one of which has attracted the interest of the Cancer Research Campaign (CRC) in the U.K. The CRC approved and funded a clinical trial for a unique fluorine imaging agent (Fluorovist®).

Responsible for all magnetic resonance imaging agent research efforts. Coordinated and supervised individual research projects towards discovery and development of novel imaging agents, including all chemical and biological support of projects. Also responsible for maintaining and coordinating collaborative outside research projects and evaluation of outside opportunities for new imaging agents. Core responsibilities also involved developing strategic planning for projects, generating project scenarios and status reports, assisting in departmental budgeting, hiring personnel as well as patent evaluation and filings.

Responsibilities included basic physical and analytical chemistry characterization of novel imaging agents, design of pre-clinical studies and evaluation of data from phase I clinical trials for diagnostic products. Gained expertise in new compound design, enhanced formulation of products, theory of acute and subchronic toxicity of lanthanide complexes, animal imaging studies, and animal and human pharmacokinetic experiment design and analysis.